A critical breakthrough in cancer investigation is emerging with the use of nanobodies to reactivate dysfunctional p53. This crucial cancer protector protein is frequently disabled in various forms of malignancies, https://businessbookmark.com/story7560986/mini-antibodies-revive-p53-new-new-pathway-for-malignant-treatment